Skip to main content
. 2026 Feb 6;17:1747121. doi: 10.3389/fphar.2026.1747121

TABLE 3.

Comparison of HPR in patients with different CYP2C19 metabolizers in matched cohorts.

Metabolic type number(n) HPR number(n) HPR rate (%) Comparison group χ 2 P
EM type 208 26 12.50 EM vs. IM 31.07 <0.01
IM type 226 77 34.07 EM vs. PM 72.32 <0.01
PM type 80 49 61.25 IM vs. PM 17.29 <0.01

Data in this table are based on propensity score-matched cohorts, HPR: high platelet reactivity.